[go: up one dir, main page]

SE9601395D0 - New therapeutic treatment 1 - Google Patents

New therapeutic treatment 1

Info

Publication number
SE9601395D0
SE9601395D0 SE9601395A SE9601395A SE9601395D0 SE 9601395 D0 SE9601395 D0 SE 9601395D0 SE 9601395 A SE9601395 A SE 9601395A SE 9601395 A SE9601395 A SE 9601395A SE 9601395 D0 SE9601395 D0 SE 9601395D0
Authority
SE
Sweden
Prior art keywords
therapeutic treatment
new therapeutic
osmolyte
inflammation
infection
Prior art date
Application number
SE9601395A
Other languages
English (en)
Swedish (sv)
Inventor
Dieter Haeussinger
Original Assignee
Dieter Haeussinger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dieter Haeussinger filed Critical Dieter Haeussinger
Priority to SE9601395A priority Critical patent/SE9601395D0/xx
Publication of SE9601395D0 publication Critical patent/SE9601395D0/xx
Priority to CA002251204A priority patent/CA2251204A1/fr
Priority to EP97920677A priority patent/EP0910361A1/fr
Priority to AU26971/97A priority patent/AU2697197A/en
Priority to PCT/EP1997/001862 priority patent/WO1997038686A1/fr
Priority to JP9536746A priority patent/JP2000508331A/ja
Priority to NO984760A priority patent/NO984760D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9601395A 1996-04-12 1996-04-12 New therapeutic treatment 1 SE9601395D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9601395A SE9601395D0 (sv) 1996-04-12 1996-04-12 New therapeutic treatment 1
CA002251204A CA2251204A1 (fr) 1996-04-12 1997-04-14 Utilisation d'un osmolyte pour traiter les effets d'une infection, d'une inflammation ou d'une dysfonction du systeme immunitaire
EP97920677A EP0910361A1 (fr) 1996-04-12 1997-04-14 Utilisation d'un osmolyte pour traiter les effets d'une infection, d'une inflammation ou d'une dysfonction du systeme immunitaire
AU26971/97A AU2697197A (en) 1996-04-12 1997-04-14 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction
PCT/EP1997/001862 WO1997038686A1 (fr) 1996-04-12 1997-04-14 Utilisation d'un osmolyte pour traiter les effets d'une infection, d'une inflammation ou d'une dysfonction du systeme immunitaire
JP9536746A JP2000508331A (ja) 1996-04-12 1997-04-14 感染、炎症または免疫障害の影響を治療するためのオスモライトの使用
NO984760A NO984760D0 (no) 1996-04-12 1998-10-12 Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601395A SE9601395D0 (sv) 1996-04-12 1996-04-12 New therapeutic treatment 1

Publications (1)

Publication Number Publication Date
SE9601395D0 true SE9601395D0 (sv) 1996-04-12

Family

ID=20402174

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601395A SE9601395D0 (sv) 1996-04-12 1996-04-12 New therapeutic treatment 1

Country Status (7)

Country Link
EP (1) EP0910361A1 (fr)
JP (1) JP2000508331A (fr)
AU (1) AU2697197A (fr)
CA (1) CA2251204A1 (fr)
NO (1) NO984760D0 (fr)
SE (1) SE9601395D0 (fr)
WO (1) WO1997038686A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
US6926911B1 (en) 1998-12-22 2005-08-09 The University Of North Carolina At Chapel Hill Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
NZ512383A (en) * 1998-12-22 2003-05-30 Univ North Carolina Use of osmotic agents in the treatment of airway diseases and for the delivery of airway drugs
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
ES2233630T3 (es) * 2000-04-12 2005-06-16 Bitop Aktiengesellschaft Fur Biotechnische Optimierung Uso de solutos compatibles como sustancias con propiedades barredoras de radicales.
WO2002013813A1 (fr) * 2000-08-11 2002-02-21 The Lawson Health Research Institute Inhibition du dysfonctionnement des îlots de langerhans et de troubles autoimmunes, et compositions à cet effet
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
WO2006050581A2 (fr) 2004-11-10 2006-05-18 Jallal Messadek Betaine en tant qu'agent de lutte contre des maladies transmises par des arthropodes ou des moustiques
BRPI0519606A2 (pt) * 2005-01-05 2009-02-25 Abdalla Magd Ahmed Kotb sÍntese, produÇço e utilidade da taurina como um remÉdio
EP2242489A1 (fr) 2005-02-15 2010-10-27 Jallal Messadek Compositions therapeutiques combinees et leurs procedes d utilisation
EP1858519B1 (fr) 2005-03-12 2013-02-20 Bitop Aktiengesellschaft Für Biotechnische Optimierung Ectoin et/u hydroxyectoin pour la prévention et le traitement des maladies inflammatoires chroniques intestinales
MX2007013486A (es) 2005-04-27 2008-03-14 Jallal Messadek Combinaciones de insulinas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728444A (en) * 1971-04-28 1973-04-17 Stanley Drug Products Inc Method and compositions for inducing resistance to bacterial infections
AU7584891A (en) * 1990-03-19 1991-10-21 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes
AU641529B2 (en) * 1990-07-30 1993-09-23 Bloomfield D.A. Zwitterionic compounds and their N-halo derivatives for use in the treatment of clinical conditions
TW282398B (fr) * 1993-12-22 1996-08-01 Bristol Myers Squibb Co
US5516798A (en) * 1994-10-11 1996-05-14 North Carolina State University Method for treating diarrhea and a composition therefor

Also Published As

Publication number Publication date
NO984760L (no) 1998-10-12
WO1997038686A1 (fr) 1997-10-23
AU2697197A (en) 1997-11-07
CA2251204A1 (fr) 1997-10-23
EP0910361A1 (fr) 1999-04-28
JP2000508331A (ja) 2000-07-04
NO984760D0 (no) 1998-10-12

Similar Documents

Publication Publication Date Title
PT880350E (pt) Tratamento de esclerose multipla
ATE199643T1 (de) Therapeutisches kombinationspräparat enthaltend interferon
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
EA200000994A1 (ru) Применение кабэрголина при лечении синдрома усталых ног
DK0777482T3 (da) Kombinationspræparat til behandling af immunsygdomme
SE9601395D0 (sv) New therapeutic treatment 1
SE9601396D0 (sv) New therapeutic treatment 2
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
MXPA01011924A (es) Metodos y composiciones para modular la respuesta inmunitaria y para el tratamiento de trastornos inflamatorios.
FI944236A0 (fi) Migreenin hoitomenetelmä
NO962259L (no) Anvendelse av dimeticon for behandling av aphthae og stomatitt
ES2104223T3 (es) 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.
ATE149840T1 (de) Behandlung von leberkrebs
DE69739482D1 (de) Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
NO962221L (no) Anvendelse av dimeticon for behandling av konstipasjon
DK0572549T3 (da) Behandling af ikke-småcellet lungecarcinom
NO995539L (no) Anvendelse av hepariner med lav molekylvekt for prevensjon og terapi av cerebrale ödemer
RU94041246A (ru) Способ лечения псориаза
NO984198L (no) FremgangsmÕte for behandling av aggresjon
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
CA2103708A1 (fr) Traitement du cancer de l'ovaire
EA199700034A2 (ru) Способ в.г.соломатова коррекции энергетического состояния живого существа
WO1999065511A3 (fr) COMPOSITION ET PROCEDE DE TRAITEMENT D'UNE INFECTION PAR $i(PSEUDOMONAS)
DE69833317D1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
RU94002713A (ru) Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)